BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Ventus Medical Release: New Approach to Initiating Sleep Apnea Therapy


10/18/2012 1:04:17 PM

SAN JOSE, Calif., Oct. 17, 2012 /PRNewswire/ -- Ventus Medical is excited to launch the all new Provent Starter Kit. The Starter Kit is specifically designed to help people with Obstructive Sleep Apnea (OSA) adjust to Provent Therapy by introducing a gradual exposure to expiratory positive airway pressure. It will be available in the US through the network of distributors currently distributing Provent Therapy.

(Photo: http://photos.prnewswire.com/prnh/20121017/SF94635)

(Logo: http://photos.prnewswire.com/prnh/20120712/LA37941LOGO)

The Provent device is placed just inside the nostrils and is held in place by a hypoallergenic adhesive. The expiratory resistance created by the Provent device helps maintain an open airway during sleep and prevents a collapse of the airway. The Starter Kit has a convenient 3-phased approach gradually increasing expiratory resistance and aiding the adjustment to Provent Therapy. The full therapeutic effect is reached on night 5. Market research has demonstrated that patients had an easier time falling asleep and slept better with the Provent Starter Kit.

"Ventus is committed to providing therapy options for the millions of people suffering from sleep disordered breathing, and we believe that this new intuitive and user friendly approach will help many more untreated people get onto and stay on therapy for OSA", says Peter Wyles, CEO and President of Ventus Medical. "We believe in providing easier and better therapeutic solutions for people suffering from sleep disordered breathing and this is another important step in this direction". Mr. Wyles adds: "Untreated OSA patients don't just suffer from quality of life issues, they are at increased risk of cardiovascular disease and diabetes. Treating OSA can significantly lower this risk, so finding an effective and tolerable patient treatment option is critical."

Provent Therapy has now been proven in more than 10 clinical trials and used in over two million nights of sleep. This unique technology, elegant design and proven efficacy makes it ideal for all OSA patient types.

About Provent® Sleep Apnea Therapy

Provent Sleep Apnea Therapy is a proprietary medical device for the treatment of obstructive sleep apnea (OSA). The device has proven to be clinically effective in a series of published studies. It is an easy to use, non-invasive disposable treatment that works across mild, moderate and severe OSA. Provent Sleep Apnea Therapy utilizes nasal expiratory positive airway pressure (EPAP) to keep a patient's airway open during sleep. It incorporates a novel MicroValve design that is placed over the nostrils and secured with hypoallergenic adhesive. During inhalation, the valve opens allowing nearly unobstructed airflow. During exhalation, the valve closes, limiting airflow through small openings, which increases expiratory pressure and keeps the airway open, preventing disruption in breathing. Provent Sleep Apnea Therapy is FDA cleared, has CE marking and has been accepted onto the Australian Register of Therapeutic Goods (ARTG). For more information, please visit www.proventtherapy.com.

About Theravent Advanced Nightly Snore Therapy

Theravent is a new, clinically proven, over-the-counter treatment for snoring. Theravent offers a proven solution for patients whose snoring is affecting the quality of their and their partners' sleep. Used nightly, Theravent gives snorers and their partners a quiet night's sleep. Theravent uses patented MicroValve Technology, previously only available with a prescription, to target and treat snoring. During inhalation, the MicroValves open--allowing nearly unobstructed airflow. During exhalation, the MicroValves partially close, which increases expiratory pressure and keeps the airway open, preventing snoring. Theravent received FDA clearance in June of 2012. Theravent is not intended to treat obstructive sleep apnea. For more information, please visit www.theravent.com.

About Ventus Medical

Ventus Medical is a privately-held medical device company dedicated to providing non-invasive medical solutions for people with sleep disordered breathing. Based on its innovative MicroValve technology and patented designs, Ventus has developed a unique line of clinically-proven medical devices to address the continuum of sleep disorders from severe obstructive sleep apnea (OSA) to mild snoring. Ventus Medical's devices work by creating expiratory positive airway pressure (EPAP). The company markets Provent Sleep Apnea Therapy, a discreet, easy-to-use nasal device, for the treatment of obstructive sleep apnea and Theravent Snore Therapy an over-the-counter device for the treatment of snoring in the US. Provent Sleep Apnea Therapy is also available in Australia, New Zealand, Hong Kong and Canada. www.ventusmedical.com

SOURCE Ventus Medical



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES